345 related articles for article (PubMed ID: 22024782)
21. Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease.
Tashkin DP; Hanania NA; McGinty J; Denis-Mize K; Chaudry I
Adv Ther; 2009 Nov; 26(11):1024-34. PubMed ID: 19953349
[TBL] [Abstract][Full Text] [Related]
22. Inhaled therapy for acute COPD exacerbation in the hospital: are we missing the low-hanging fruit?
Patel DC; Ashton RW
South Med J; 2011 Nov; 104(11):746. PubMed ID: 22024783
[No Abstract] [Full Text] [Related]
23. Inhalatory therapy training: a priority challenge for the physician.
Melani AS
Acta Biomed; 2007 Dec; 78(3):233-45. PubMed ID: 18330086
[TBL] [Abstract][Full Text] [Related]
24. Combination inhaled bronchodilator therapy in the management of chronic obstructive pulmonary disease.
Nichols J
Pharmacotherapy; 2007 Mar; 27(3):447-54. PubMed ID: 17316155
[TBL] [Abstract][Full Text] [Related]
25. COPD patient satisfaction with ipratropium bromide/albuterol delivered via Respimat: a randomized, controlled study.
Ferguson GT; Ghafouri M; Dai L; Dunn LJ
Int J Chron Obstruct Pulmon Dis; 2013; 8():139-50. PubMed ID: 23658479
[TBL] [Abstract][Full Text] [Related]
26. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J
Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474
[TBL] [Abstract][Full Text] [Related]
27. Bronchodilators in patients with chronic obstructive pulmonary disease on mechanical ventilation. Utilization of metered-dose inhalers.
Fernandez A; Lazaro A; Garcia A; Aragon C; Cerda E
Am Rev Respir Dis; 1990 Jan; 141(1):164-8. PubMed ID: 2136979
[TBL] [Abstract][Full Text] [Related]
28. Dry powder ipratropium bromide is as safe and effective as metered-dose inhaler formulation: a cumulative dose-response study in chronic obstructive pulmonary disease patients.
Cuvelier A; Muir JF; Benhamou D; Weitzenblum E; Zuck P; Delacenserie R; Taytard A; Iacono P
Respir Care; 2002 Feb; 47(2):159-66. PubMed ID: 11812272
[TBL] [Abstract][Full Text] [Related]
29. Comparing COPD treatment: nebulizer, metered dose inhaler, and concomitant therapy.
Tashkin DP; Klein GL; Colman SS; Zayed H; Schonfeld WH
Am J Med; 2007 May; 120(5):435-41. PubMed ID: 17466655
[TBL] [Abstract][Full Text] [Related]
30. Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: a one year evaluation of safety and tolerance.
Donohue JF; Hanania NA; Sciarappa KA; Goodwin E; Grogan DR; Baumgartner RA; Hanrahan JP
Ther Adv Respir Dis; 2008 Apr; 2(2):37-48. PubMed ID: 19124357
[TBL] [Abstract][Full Text] [Related]
31. Effect of long-acting beta-agonists on the frequency of COPD exacerbations: a meta-analysis.
Wang J; Nie B; Xiong W; Xu Y
J Clin Pharm Ther; 2012 Apr; 37(2):204-11. PubMed ID: 21740451
[TBL] [Abstract][Full Text] [Related]
32. A respiratory therapist-directed protocol for managing inpatients with asthma and COPD incorporating a long-acting bronchodilator.
Colice GL; Carnathan B; Sung J; Paramore LC
J Asthma; 2005 Feb; 42(1):29-34. PubMed ID: 15801325
[TBL] [Abstract][Full Text] [Related]
33. Beclomethasone/formoterol in the management of COPD: a randomised controlled trial.
Calverley PM; Kuna P; Monsó E; Costantini M; Petruzzelli S; Sergio F; Varoli G; Papi A; Brusasco V
Respir Med; 2010 Dec; 104(12):1858-68. PubMed ID: 20965712
[TBL] [Abstract][Full Text] [Related]
34. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease.
Balkissoon R; Make B
COPD; 2008 Aug; 5(4):221-7. PubMed ID: 18671147
[TBL] [Abstract][Full Text] [Related]
35. Subutilization of COPD guidelines in primary care: a pilot study.
Laniado-Laborín R; Rendón A; Alcantar-Schramm JM; Cazares-Adame R; Bauerle O
J Prim Care Community Health; 2013 Jul; 4(3):172-6. PubMed ID: 23799703
[TBL] [Abstract][Full Text] [Related]
36. Adherence to inhaled therapy, mortality and hospital admission in COPD.
Vestbo J; Anderson JA; Calverley PM; Celli B; Ferguson GT; Jenkins C; Knobil K; Willits LR; Yates JC; Jones PW
Thorax; 2009 Nov; 64(11):939-43. PubMed ID: 19703830
[TBL] [Abstract][Full Text] [Related]
37. Salbutamol and ipratropium by inhaler is superior to nebulizer in children with severe acute asthma exacerbation: Randomized clinical trial.
Iramain R; Castro-Rodriguez JA; Jara A; Cardozo L; Bogado N; Morinigo R; De Jesús R
Pediatr Pulmonol; 2019 Apr; 54(4):372-377. PubMed ID: 30672140
[TBL] [Abstract][Full Text] [Related]
38. Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial.
Tashkin DP; Littner M; Andrews CP; Tomlinson L; Rinehart M; Denis-Mize K
Respir Med; 2008 Apr; 102(4):479-87. PubMed ID: 18258423
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the bronchodilating effects of albuterol delivered by valved vs. non-valved spacers in pediatric asthma.
Rodriguez-Martinez CE; Sossa-Briceño MP; Castro-Rodriguez JA
Pediatr Allergy Immunol; 2012 Nov; 23(7):629-35. PubMed ID: 23005919
[TBL] [Abstract][Full Text] [Related]
40. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
Eiser NM; Phillips C; Wooler PA
Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
